UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000040698
Receipt No. R000046456
Scientific Title Diagnostic ulcerative colitis assosiated neoplasia with endocytoscopy
Date of disclosure of the study information 2020/06/12
Last modified on 2020/06/09 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Diagnostic ulcerative colitis assosiated neoplasia with endocytoscopy
Acronym EC-UCAN
Scientific Title Diagnostic ulcerative colitis assosiated neoplasia with endocytoscopy
Scientific Title:Acronym EC-UCAN
Region
Japan

Condition
Condition Ulcerative colitis
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of this retrospective study was to demonstrate the diagnostic ability of combined EC irregularly-formed nuclei with PIT (EC-IN-PIT)
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We evaluated and compared the diagnostic abilities of PIT alone and EC-IN-PIT.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients with UC whose lesions were observed by EC at the Showa University Northern Yokohama Hospital between February 2007 and April 2020.
Key exclusion criteria Exclusion criteria were lesions histologically diagnosed as sporadic neoplasia, nondifferentiable lesions between UCAN and sporadic neoplasia, and nondifferentiable lesions between neoplasia and non-neoplasia.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Shin-ei
Middle name
Last name Kudo
Organization Showa University Northern Yokohama Hospital
Division name Digestive Disease Center
Zip code 224-8503
Address 35-1 Chigasakichuo Tuduki-ku Yokohama
TEL 0459497000
Email kudos@med.showa-u.ac.jp

Public contact
Name of contact person
1st name Yasuharu
Middle name Wakamura
Last name Maeda
Organization Showa University Northern Yokohama Hospital
Division name Digestive Disease Center
Zip code 224-8503
Address 35-1 Chigasakichuo Tuduki-ku Yokohama
TEL 0459497000
Homepage URL
Email yasuharumaeda610@hotmail.com

Sponsor
Institute Digestive Disease Center, Showa University Northern Yokohama Hospital
Institute
Department

Funding Source
Organization JSPS KAKENHI
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Showa University Northern Yokohama Hospital IRB
Address 35-1 Chigasakichuo Tuduki-ku
Tel +81459497000
Email irb02syh@ofc.showa-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 103
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 05 Month 05 Day
Date of IRB
2020 Year 06 Month 12 Day
Anticipated trial start date
2020 Year 05 Month 15 Day
Last follow-up date
2020 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information First Strategy: PIT alone diagnosis.
Second Strategy: EC-IN-PIT (combined EC irregular nuclei with PIT) diagnosis:

Management information
Registered date
2020 Year 06 Month 09 Day
Last modified on
2020 Year 06 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046456